The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer

Maria Iyali Torres-Bustamante,Jorge Raul Vazquez-Urrutia,Fabiola Solorzano-Ibarra,Pablo Cesar Ortiz-Lazareno
DOI: https://doi.org/10.3390/ijms25042178
IF: 5.6
2024-02-12
International Journal of Molecular Sciences
Abstract:Bladder cancer (BC) is one of the most common types of cancer worldwide, with significant differences in survival depending on the degree of muscle and surrounding tissue invasion. For this reason, the timely detection and monitoring of the disease are important. Surveillance cystoscopy is an invasive, costly, and uncomfortable procedure to monitor BC, raising the need for new, less invasive alternatives. In this scenario, microRNAs (miRNAs) represent attractive prognostic tools given their role as gene regulators in different biological processes, tissue expression, and their ease of evaluation in liquid samples. In cancer, miRNA expression is dynamically modified depending on the tumor type and cancer staging, making them potential biomarkers. This review describes the most recent studies in the last five years exploring the utility of miRNA-based strategies to monitor progression, stratify, and predict relevant clinical outcomes of bladder cancer. Several studies have shown that multimarker miRNA models can better predict overall survival, recurrence, and progression in BC patients than traditional strategies, especially when combining miRNA expression with clinicopathological variables. Future studies should focus on validating their use in different cohorts and liquid samples.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main purpose of this paper is to explore the role of microRNAs (miRNAs) in bladder cancer (BC), particularly in the application of detecting disease progression, risk stratification, and predicting clinical outcomes. Specifically, the paper reviews the research progress on miRNAs in monitoring bladder cancer, predicting recurrence, and progression over the past 5 years. ### Main Issues: 1. **Non-invasive Monitoring**: The currently commonly used cystoscopy, although effective, is invasive and costly. Therefore, there is a need to develop new non-invasive methods to monitor bladder cancer. 2. **Biomarker Research**: Finding more precise biomarkers to improve the accuracy of detecting disease progression and recurrence, reduce the need for cystoscopy, and enhance the performance of risk classification systems. 3. **Role of miRNAs**: Exploring the role of miRNAs as gene regulatory factors in different biological processes and their potential application as biomarkers in liquid biopsy samples. ### Research Methods: - The paper reviewed the latest studies related to miRNAs and bladder cancer in the PubMed database, selecting relevant literature from the past 5 years. - Analyzed the expression levels of multiple miRNAs in bladder cancer tissues and liquid biopsy samples, and evaluated their potential as indicators for diagnosis, prognosis, and therapeutic response. ### Conclusion: - Multiple studies have shown that multi-marker miRNA models can more accurately predict overall survival, recurrence rates, and disease progression in bladder cancer patients compared to traditional strategies. - Future research should focus on validating the application of these miRNA biomarkers in different cohorts and sample types.